05:29 PM EST, 11/27/2024 (MT Newswires) -- Pushkal Garg, CMO & EVP Dev & Med Affairs, on Nov. 25 and Nov. 26, sold 1,682 shares in Alnylam Pharmaceuticals ( ALNY ) for $422,144. Following the Form 4 filing with the SEC, Garg has control over a total of 18,138 shares of the company, with 17,457 shares held directly and 681 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1178670/000173527624000107/xslF345X05/edgardoc.xml